Sun Pharma is currently trading around ₹1610, showing signs of stabilization after a corrective decline. On the daily chart, the
SUNPHARMA
stock has recently rebounded from the ₹1580 support zone, where buyers stepped in to defend the level.
Moving Averages (MAs): The
SUNPHARMA
stock is trading below its short-term and medium-term moving averages (20, 50, and 100 DMA), which are currently acting as resistance in the ₹1630–1650 zone. A breakout and sustained close above these averages will confirm strength and may open the door for further upside toward ₹1685–1720 levels. On the downside, the 200
SUNPHARMA
DMA near ₹1550 is a
SUNPHARMA
strong support level.
Parabolic SAR: Dots are still above the price, signaling that the short-term trend is yet to fully reverse into a confirmed bullish trend. A few more positive candles may flip the SAR below the price, indicating buying momentum.
RSI (Relative Strength Index): RSI is at
SUNPHARMA
49, hovering around the neutral zone, which shows neither overbought nor oversold conditions. This means the stock is at a make-or-break zone, where the next move could set the short-term direction.
SUNPHARMA
MACD (Moving Average Convergence Divergence): The MACD line is below the signal line but flattening, suggesting that downside momentum is slowing. If crossover happens in the coming sessions, it will generate a bullish momentum signal.
Summary View
Support Levels: ₹1580 – ₹1550
Resistance Levels: ₹1630 – ₹1650 (immediate), ₹1685 – ₹1720 (next)
Trend Outlook: Stock is in consolidation with a bias shifting towards recovery. Sustaining above ₹1650 will attract fresh buying interest.